Ypozane® Summary Information:
Benign Prostatic Hypertrophy (BPH) in male dogs is a natural consequence of ageing. More than 80% of male dogs over the age of five years are affected.
Clinically, BPH may present as:
difficulty in defaecation and urination,
- abdominal pain,
- locomotory disorders.
In many cases such manifestations may not be spontaneously associated with BPH.
Ypozane® is a novel, non-invasive solution to BPH that preserves reproductive function.
The active ingredient of Ypozane® is osaterone acetate which works by blocking the effects of androgens in the prostate by inhibiting testosterone uptake and acts as a competitive antagonist on androgen receptors. This produces a rapid and marked reduction in the size of the prostate and a long lasting remission of associated clinical signs.
|Weight||Ypozane® tablet size||Number of tablets to be given daily||Treatment duration|
|3 -7.5 kg||1.875 mg tablet||1 TABLET||7 DAYS|
|7.5 to 15 kg||3.75 mg tablet||1 TABLET||7 DAYS|
|15 to 30 kg||7.5 mg tablet||1 TABLET||7 DAYS|
|30 to 60 kg||15 mg tablet||1 TABLET||7 DAYS|
The information shown by this tab can only be viewed by registered users.
This website allows registered vet and non-vet animal professionals access to more detailed product information. If you already have a user account with Virbac UK click on the 'Login' button below, alternatively click on the 'Register' button to set up a new account.
The following resources are available for this product. To view or download a resource click on the item.